USANA Health Sciences, Inc.

NYSE:USNA Rapport sur les actions

Capitalisation boursière : US$767.4m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

USANA Health Sciences Gestion

Gestion contrôle des critères 3/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Jim Brown

Directeur général

US$2.5m

Rémunération totale

Pourcentage du salaire du PDG28.7%
Durée du mandat du directeur général7.8yrs
Propriété du PDGn/a
Durée moyenne d'occupation des postes de direction7.5yrs
Durée moyenne du mandat des membres du conseil d'administration6.5yrs

Mises à jour récentes de la gestion

Recent updates

USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 26
USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding

Jul 17
There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding

USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively

May 29
USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively

USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 03
USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?

May 01
Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?

USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares

Apr 04
USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares

USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Feb 08
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

Jan 06
Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation

Oct 23

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Sep 09
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

Jul 27
Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

USANA Earnings Preview: From China's Challenge To India's Promise

Jul 21

USANA Health Sciences says Brown will transition to CEO in July 2023

Feb 13

Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

Feb 02
Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates

Oct 25

Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Oct 18
Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Jul 22
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Jul 07
Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Jun 14
Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?

May 31
Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?

USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside

Apr 28

Analyse de la rémunération des PDG

Comment la rémunération de Jim Brown a-t-elle évolué par rapport aux bénéfices de USANA Health Sciences?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 29 2024n/an/a

US$55m

Mar 30 2024n/an/a

US$62m

Dec 30 2023US$2mUS$710k

US$64m

Sep 30 2023n/an/a

US$60m

Jul 01 2023n/an/a

US$63m

Apr 01 2023n/an/a

US$65m

Dec 31 2022US$2mUS$624k

US$69m

Oct 01 2022n/an/a

US$77m

Jul 02 2022n/an/a

US$89m

Apr 02 2022n/an/a

US$108m

Jan 01 2022US$2mUS$600k

US$117m

Oct 02 2021n/an/a

US$136m

Jul 03 2021n/an/a

US$139m

Apr 03 2021n/an/a

US$129m

Jan 02 2021US$2mUS$599k

US$125m

Sep 26 2020n/an/a

US$116m

Jun 27 2020n/an/a

US$110m

Mar 28 2020n/an/a

US$103m

Dec 28 2019US$2mUS$559k

US$101m

Sep 28 2019n/an/a

US$102m

Jun 29 2019n/an/a

US$109m

Mar 30 2019n/an/a

US$121m

Dec 29 2018US$2mUS$534k

US$126m

Sep 29 2018n/an/a

US$88m

Jun 30 2018n/an/a

US$81m

Mar 31 2018n/an/a

US$70m

Dec 30 2017US$1mUS$523k

US$63m

Rémunération vs marché: La rémunération totale de Jim ($USD 2.47M ) est dans la moyenne des entreprises de taille similaire sur le marché US ($USD 3.30M ).

Rémunération et revenus: La rémunération de Jim a augmenté de plus de 20 % tandis que les bénéfices de l'entreprise ont chuté de plus de 20 % au cours de l'année écoulée.


PDG

Jim Brown (55 yo)

7.8yrs

Titularisation

US$2,472,017

Compensation

Mr. Jim Brown has been the President of USANA Health Sciences Inc. since November 2016 and served as its Chief Operating Officer since November 2013 until October 2019. He serves as Chief Executive Officer...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Kevin Guest
Executive Chairman7.3yrsUS$3.91m0.064%
$ 490.5k
Jim Brown
CEO & President7.8yrsUS$2.47mpas de données
G. Hekking
Chief Financial Officer7.3yrsUS$1.47m0%
$ 0
Walter Noot
Chief Operating Officer4.8yrsUS$1.42mpas de données
P. Foukas
Chief Legal Officer6.1yrsUS$1.29mpas de données
Daniel Macuga
Chief Communications & Marketing Officer12.7yrsUS$1.15m0%
$ 0
Myron Wentz
Founder & Chairman Emeritus32.6yrspas de données41.28%
$ 316.8m
John Cuomo
Executive Director of Product Development & Technology11.7yrspas de donnéespas de données
Robert Sinnott
Chief Scientific Officer8yrspas de donnéespas de données
Peter Benedict
Chief Information Officerno datapas de donnéespas de données
Patrique Richards
Executive Director of Investor Relations & Business Developmentno datapas de donnéespas de données
Paul Jones
Chief People Officer3.5yrsUS$637.78k0%
$ 0

7.5yrs

Durée moyenne de l'emploi

58yo

Âge moyen

Gestion expérimentée: L'équipe de direction de USNA est chevronnée et expérimentée (ancienneté moyenne 7.5 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Kevin Guest
Executive Chairman7.3yrsUS$3.91m0.064%
$ 490.5k
Myron Wentz
Founder & Chairman Emeritus4.3yrspas de données41.28%
$ 316.8m
Gilbert Fuller
Lead Independent Director15.9yrsUS$251.60k0%
$ 0
Peggie Pelosi
Independent Director5.7yrsUS$231.40k0.019%
$ 146.4k
Timothy Wood
Independent Director4.8yrsUS$218.40k0.031%
$ 238.7k
Christine Wood
Member of Scientific Advisory Councilno datapas de donnéespas de données
Monica Lewis
Member of Scientific Advisory Councilno datapas de donnéespas de données
Peter Rugg
Chairperson of Scientific Advisory Council20.6yrspas de donnéespas de données
Bart Moore
Member of Scientific Advisory Councilno datapas de donnéespas de données
Heather Tick
Member of Scientific Advisory Councilno datapas de donnéespas de données
Frederic Winssinger
Independent Director8.3yrsUS$233.60k0.020%
$ 155.0k
J. Nixon
Independent Director2.1yrsUS$218.40k0.019%
$ 143.4k

6.5yrs

Durée moyenne de l'emploi

68yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de USNA sont considérés comme expérimentés (ancienneté moyenne 6.5 ans).